Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
9 Meters Biopharma Inc. (OTC : NMTRQ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003 and others.
Quote
| Last: | $0.0001 |
|---|---|
| Change Percent: | 9900.0% |
| Open: | $1e-06 |
| Close: | $0.0001 |
| High: | $0.0001 |
| Low: | $0 |
| Volume: | 4,746 |
| Last Trade Date Time: | 09/16/2026 11:35:29 am |
Stock Data
| Market Cap: | $1,446 |
|---|---|
| Float: | 14,315,093 |
| Insiders Ownership: | 0.28% |
| Institutions: | 8 |
| Short Percent: | 586596% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.9meters.com |
| Country: | US |
| City: | Raleigh |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about 9 Meters Biopharma Inc. (OTC: NMTRQ).
